Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vecchiet

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
The International Journal of Biological Markers|October 9, 2007
Localization and activity of iNOS in normal human lung tissue and lung cancer tissueL Speranza, M A De Lutiis, Y B Shaik, et al.
Journal of Biological Regulators and Homeostatic Agents|March 27, 2009
The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activatorM L Castellani, D Kempuraj, V Salini, et al.
International Journal of Immunopathology and Pharmacology|February 13, 2003
-Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacyG Parruti, P Tarquini, K Falasca, et al.
Journal of Biological Regulators and Homeostatic Agents|May 22, 2010
IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg CellsMaria Luisa Castellani, A Anogeianaki, P Felaco, et al.
International Journal of Immunopathology and Pharmacology|June 13, 2008
Biology of neurotensin: revisited studyG S Katsanos, A Anogianaki, M L Castellani, et al.
International Journal of Immunopathology and Pharmacology|March 25, 2009
Autism and immunity: revisited studyM L Castellani, C M Conti, D J Kempuraj, et al.
Journal of Biological Regulators and Homeostatic Agents|October 16, 2009
IL-32: a newly-discovered proinflammatory cytokineP Felaco, M L Castellani, M A De Lutiis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2018
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitroR Salpini, M Surdo, M F Cortese, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsV C Di Maio, V Cento, D Di Paolo, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The International Journal of Biological Markers|October 9, 2007
Localization and activity of iNOS in normal human lung tissue and lung cancer tissueL Speranza, M A De Lutiis, Y B Shaik, et al.
Journal of Biological Regulators and Homeostatic Agents|March 27, 2009
The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activatorM L Castellani, D Kempuraj, V Salini, et al.
International Journal of Immunopathology and Pharmacology|February 13, 2003
-Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacyG Parruti, P Tarquini, K Falasca, et al.
Journal of Biological Regulators and Homeostatic Agents|May 22, 2010
IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg CellsMaria Luisa Castellani, A Anogeianaki, P Felaco, et al.
International Journal of Immunopathology and Pharmacology|June 13, 2008
Biology of neurotensin: revisited studyG S Katsanos, A Anogianaki, M L Castellani, et al.
International Journal of Immunopathology and Pharmacology|March 25, 2009
Autism and immunity: revisited studyM L Castellani, C M Conti, D J Kempuraj, et al.
Journal of Biological Regulators and Homeostatic Agents|October 16, 2009
IL-32: a newly-discovered proinflammatory cytokineP Felaco, M L Castellani, M A De Lutiis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2018
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitroR Salpini, M Surdo, M F Cortese, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsV C Di Maio, V Cento, D Di Paolo, et al.
Pageof 6